A deep dive into the influence of research output, patenting, venture capital and human capital on startup financing activity in Europe reveals not all countries are equal.
References
Alstadsæter, A., Barrios, S., Nicodeme, G., Skonieczna, A.M. & Vezzani, A. European Commission IPTS Working Papers on Corporate R&D and Innovation – No. 6/2015, Patent boxes design, patents location and local R&D. https://ec.europa.eu/jrc/sites/jrcsh/files/JRC96080_Patent_boxes.pdf (2015).
Stevens, A. J. Nat. Biotechnol. 35, 608–613 (2017).
Acs, Z.J., Szerb, L. & Lloyd, A. 2017 Global Entrepreneurship Index http://thegedi.org/product/2017-global-entrepreneurship-index/ (2017).
Liñán, F. & Fernandez-Serrano, J. Small Bus. Econ. 42, 685–701 (2014).
Rooswinkel, R. W., Berbers, D. S. W., Claassen, E. H. J. H. M. & van Deventer, S. Nat. Biotechnol. 34, 1095–1098 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
B.v.W., S.v.D. and R.W.R. are employed by Forbion Capital Partners, which invests in biotech ventures.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary Methods and Supplementary Tables 1 and 2
Supplementary Data
Raw data for the European analysis
Rights and permissions
About this article
Cite this article
van Wilgenburg, B., van Wilgenburg, K., Paisner, K. et al. Mapping the European startup landscape. Nat Biotechnol 37, 345–349 (2019). https://doi.org/10.1038/s41587-019-0076-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-019-0076-4
- Springer Nature America, Inc.
This article is cited by
-
The BioInnovation Institute as a catalyst for European life science startup creation
Nature Biotechnology (2022)